ONE-WAYOngoing theme · still written in the latest filings
Concentration of R&D resources on boron drugs for BNCT
A theme centred on boron drugs for BNCT (boron neutron capture therapy) as the core of a single pharmaceutical development programme, with R&D resources continuously concentrated on expanding indications and advancing the development pipeline.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.